首页 > 市场调查报告书 > 医疗设备

体外诊断

纸本诊断市场规模、份额和成长分析（按产品类型、设备类型、应用、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1899314

纸本诊断市场规模、份额和成长分析（按产品类型、设备类型、应用、最终用户和地区划分）－2026-2033年产业预测

Paper Diagnostics Market Size, Share, and Growth Analysis, By Product (Dipsticks, Lateral Flow Assays), By Device Type (Monitoring Devices, Diagnostic Devices), By Application, By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，纸基诊断市场规模将达到 163.8 亿美元，到 2025 年将达到 176.7 亿美元，到 2033 年将达到 324.7 亿美元，在预测期（2026-2033 年）内复合年增长率为 7.9%。

纸本诊断市场正迅速崛起，成为就地检验领域的重要力量，为各种环境下的快速医疗诊断提供便携且经济高效的解决方案，尤其是在偏远和资源匮乏的地区。其主要优点包括易于使用、所需设备极少，以及能够有效检测疟疾、爱滋病和糖尿病等疾病。由于生产成本低、处置方便且减少了对专业人员的依赖，纸本诊断在环境监测和食品安全应用领域也日益普及。对即时、分散式医疗服务的需求，尤其是在医疗资源匮乏的地区，进一步推动了市场成长。儘管仍面临诸如确保结果准确性和扩大可检测分析物范围等挑战，但研发和製造技术的进步以及合作有望推动这一创新领域的持续发展。

推动纸本诊断市场发展的因素

纸本诊断市场的主要驱动力在于，这些工具能够实现就地检验，提供快速且经济高效的结果。这项创新提高了传统检测设施有限或缺乏的偏远地区和医疗资源匮乏地区的诊断和治疗速度及可及性。纸本诊断工具使医护人员能够提供即时护理，在改善病患预后和消除医疗资源不平等方面发挥着至关重要的作用。其易用性和经济性使医护人员能够更快地做出更明智的决策，最终有助于在各种环境下提供更有效率的医疗服务。

纸本诊断市场的限制因素

由于医疗系统对传统诊断方法的过度依赖，纸基诊断市场面临严峻的挑战。这种依赖使得纸基诊断的整合变得复杂，并常常阻碍其成为有效的替代方案或补充方案。医疗专业人员可能不愿采用这些新技术，而是优先考虑那些长期以来因其准确性和可靠性而备受信赖的成熟方法。因此，向创新纸基诊断解决方案的过渡进展缓慢，限制了这些技术进步在各种临床环境中的潜在成长和普及。这种情况对纸基诊断市场构成了重大阻碍因素。

纸本诊断市场的发展趋势

纸本诊断市场正经历强劲成长，这主要得益于就地检验（POCT）需求的不断增长，POCT强调诊断流程的快速性和便利性。这一趋势反映了医疗保健向分散式模式转变的趋势，在这种模式下，快速且方便的检测解决方案至关重要。纸本诊断技术以其成本效益和易用性而着称，使医护人员和患者无需依赖复杂的实验室设备即可获得即时结果。随着医疗保健系统日益重视效率和便利性，纸本诊断技术的应用有望在改善患者照护和简化临床工作流程方面发挥关键作用。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Abbott Laboratories（USA）
Bio-Rad Laboratories（USA）
Siemens Healthineers（Germany）
Abcam Plc（UK）
Chembio Diagnostic Systems Inc.（USA）
ACON Laboratories Inc.（USA）
FFEI（UK）
ARKRAY Inc.（Japan）
Creative Diagnostics（USA）
OraSure Technologies, Inc.（USA）
Quidel Corporation（USA）
Thermo Fisher Scientific Inc.（USA）
Danaher Corporation（USA）
Becton, Dickinson and Company（BD）（USA）
Roche Diagnostics（Switzerland）
PerkinElmer Inc.（USA）
Sysmex Corporation（Japan）
bioMerieux SA（France）
Hologic, Inc.（USA）
Merck KGaA（Germany）

结论与建议

简介目录

Product Code: SQMIG35H2179

Paper Diagnostics Market size was valued at USD 16.38 Billion in 2024 and is poised to grow from USD 17.67 Billion in 2025 to USD 32.47 Billion by 2033, growing at a CAGR of 7.9% during the forecast period (2026-2033).

The paper diagnostics market has emerged as a significant player in point-of-care testing, offering transportable and cost-effective solutions for rapid medical diagnostics across diverse settings, especially in remote or resource-limited areas. Key advantages include ease of use, minimal equipment requirements, and effective disease detection capabilities for conditions such as malaria, HIV, and diabetes. With inexpensive manufacturing, simple disposal, and reduced need for specialized staff, paper diagnostics are increasingly favored for applications in environmental monitoring and food safety. The drive for immediate, decentralized healthcare, particularly in underserved regions, has further accelerated market growth. Despite challenges like ensuring result accuracy and broadening detectable analytes, advancements in research, manufacturing, and collaborations promise continued expansion in this innovative field.

Top-down and bottom-up approaches were used to estimate and validate the size of the Paper Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Paper Diagnostics Market Segments Analysis

Global Paper Diagnostics Market is segmented by Product, Device Type, Application, End-User and region. Based on Product, the market is segmented into Dipsticks, Lateral Flow Assays and Paper-Based Microfluidics. Based on Device Type, the market is segmented into Monitoring Devices and Diagnostic Devices. Based on Application, the market is segmented into Environmental Monitoring, Clinical Diagnostics and Food Quality Testing. Based on End-User, the market is segmented into Home Healthcare, Assisted Living Healthcare Facilities and Hospitals and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Paper Diagnostics Market

The paper diagnostics market is significantly driven by the ability of these tools to facilitate point-of-care testing, delivering rapid and cost-effective results. This innovation enhances the speed and accessibility of diagnosis and treatment, particularly in underserved or rural areas where conventional laboratory facilities may be limited or unavailable. By allowing healthcare providers to deliver immediate care, paper diagnostics play a crucial role in improving patient outcomes and addressing healthcare disparities. Their ease of use and affordability empower healthcare professionals to make informed decisions quickly, ultimately contributing to more efficient healthcare delivery in diverse settings.

Restraints in the Paper Diagnostics Market

The Paper Diagnostics market faces significant challenges due to the entrenched reliance of healthcare systems on conventional diagnostic methods. This dependence complicates the integration of paper diagnostics, often hindering their ability to serve as effective alternatives or supplements. Healthcare professionals may be hesitant to adopt these new technologies, prioritizing established practices that have long been trusted for accuracy and reliability. Consequently, the transition towards innovative paper-based diagnostic solutions is slowed, limiting the potential growth and acceptance of these advancements in various clinical settings. This dynamic creates a substantial restraint within the Paper Diagnostics market.

Market Trends of the Paper Diagnostics Market

The Paper Diagnostics market is witnessing robust growth fueled by the escalating demand for point-of-care testing, which prioritizes speed and accessibility in diagnostic procedures. This trend reflects a broader shift towards decentralized healthcare, where rapid and user-friendly testing solutions are essential. Paper-based diagnostic technologies, known for their cost-effectiveness and ease of use, empower healthcare professionals and patients alike to obtain immediate results without relying on complex laboratory equipment. As healthcare systems increasingly emphasize efficiency and convenience, the adoption of paper diagnostics is set to play a pivotal role in enhancing patient care and streamlining clinical workflows.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Patent Analysis

Global Paper Diagnostics Market Size by Product & CAGR (2026-2033)

Market Overview
Dipsticks
Lateral Flow Assays
Paper-Based Microfluidics

Global Paper Diagnostics Market Size by Device Type & CAGR (2026-2033)

Market Overview
Monitoring Devices
Diagnostic Devices

Global Paper Diagnostics Market Size by Application & CAGR (2026-2033)

Market Overview
Environmental Monitoring
Clinical Diagnostics
Food Quality Testing

Global Paper Diagnostics Market Size by End-User & CAGR (2026-2033)

Market Overview
Home Healthcare
Assisted Living Healthcare Facilities
Hospitals and Clinics

Global Paper Diagnostics Market Size & CAGR (2026-2033)

North America (Product, Device Type, Application, End-User)
- US
- Canada
Europe (Product, Device Type, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Device Type, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Device Type, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Device Type, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abcam Plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chembio Diagnostic Systems Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACON Laboratories Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FFEI (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ARKRAY Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Diagnostics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OraSure Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments